BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,647 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q2 2023 | $4,647 | +12.3% | 102 | 0.0% | 0.00% | – |
| Q1 2023 | $4,137 | -20.4% | 102 | 0.0% | 0.00% | – |
| Q4 2022 | $5,199 | +4.0% | 102 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 102 | +1.0% | 0.00% | – |
| Q2 2022 | $6,000 | -25.0% | 101 | +3.1% | 0.00% | – |
| Q1 2022 | $8,000 | -84.6% | 98 | -84.7% | 0.00% | -100.0% |
| Q3 2020 | $52,000 | +79.3% | 641 | +89.1% | 0.02% | +46.7% |
| Q2 2020 | $29,000 | -94.3% | 339 | -94.4% | 0.02% | -93.7% |
| Q4 2019 | $507,000 | +576.0% | 6,059 | +602.1% | 0.24% | +720.7% |
| Q3 2019 | $75,000 | +97.4% | 863 | +88.4% | 0.03% | +123.1% |
| Q2 2019 | $38,000 | +1800.0% | 458 | +1808.3% | 0.01% | +1200.0% |
| Q1 2019 | $2,000 | -97.4% | 24 | -97.9% | 0.00% | -95.8% |
| Q4 2018 | $76,000 | +58.3% | 1,149 | +82.7% | 0.02% | +118.2% |
| Q3 2018 | $48,000 | -84.0% | 629 | -84.5% | 0.01% | -92.2% |
| Q2 2018 | $300,000 | +5.6% | 4,070 | -7.0% | 0.14% | +5.2% |
| Q1 2018 | $284,000 | +29.1% | 4,375 | +28.5% | 0.13% | +17.5% |
| Q4 2017 | $220,000 | +2.8% | 3,405 | 0.0% | 0.11% | -0.9% |
| Q3 2017 | $214,000 | +3.9% | 3,405 | 0.0% | 0.12% | -10.2% |
| Q2 2017 | $206,000 | -78.2% | 3,405 | -81.3% | 0.13% | -79.4% |
| Q1 2017 | $945,000 | +594.9% | 18,205 | +510.9% | 0.62% | +377.7% |
| Q4 2016 | $136,000 | -86.6% | 2,980 | -86.0% | 0.13% | -80.5% |
| Q3 2016 | $1,014,000 | +25250.0% | 21,301 | +16541.4% | 0.67% | +33300.0% |
| Q3 2015 | $4,000 | -99.9% | 128 | -99.7% | 0.00% | -99.8% |
| Q2 2015 | $2,946,000 | +2.1% | 42,128 | 0.0% | 0.95% | +35.7% |
| Q1 2015 | $2,886,000 | -6.7% | 42,128 | -0.2% | 0.70% | +13.9% |
| Q4 2014 | $3,094,000 | -60.9% | 42,212 | -62.9% | 0.61% | -9.7% |
| Q4 2013 | $7,906,000 | +79.1% | 113,667 | +69.2% | 0.68% | +101.5% |
| Q3 2013 | $4,414,000 | +21.5% | 67,188 | +28.1% | 0.34% | +10.5% |
| Q2 2013 | $3,632,000 | +185.3% | 52,438 | +199.3% | 0.30% | +242.7% |
| Q1 2013 | $1,273,000 | -73.8% | 17,522 | -75.9% | 0.09% | -77.1% |
| Q4 2012 | $4,854,000 | +11.2% | 72,824 | +0.5% | 0.39% | +14.7% |
| Q3 2012 | $4,366,000 | +21.9% | 72,446 | +7.5% | 0.34% | +16.9% |
| Q2 2012 | $3,581,000 | +20.3% | 67,380 | +35.4% | 0.29% | +25.0% |
| Q1 2012 | $2,976,000 | -37.3% | 49,780 | -48.1% | 0.23% | -44.2% |
| Q4 2011 | $4,744,000 | -30.4% | 95,880 | -24.9% | 0.42% | +27.2% |
| Q3 2011 | $6,813,000 | +54.6% | 127,730 | +46.1% | 0.33% | +59.5% |
| Q2 2011 | $4,407,000 | +583.3% | 87,400 | +628.3% | 0.20% | +294.2% |
| Q1 2011 | $645,000 | +6.3% | 12,000 | 0.0% | 0.05% | -1.9% |
| Q4 2010 | $607,000 | -81.5% | 12,000 | -78.7% | 0.05% | -83.0% |
| Q1 2010 | $3,278,000 | +28.9% | 56,330 | +30.0% | 0.31% | +23.9% |
| Q4 2009 | $2,543,000 | -49.3% | 43,330 | -55.7% | 0.25% | -66.3% |
| Q1 2009 | $5,012,000 | – | 97,855 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |